Dupilumab-associated ulcerative keratitis

Matthew M Wilson¹, Philipp K Roberts^{1

2}, Mark Daniell^{1

3

4}

Affiliations

¹ Corneal Service, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria 3002, Australia.
² Medical University of Vienna, Vienna 1090, Austria.
³ Department of Surgery (Ophthalmology), University of Melbourne, Parkville, VIC 3013, Australia.
⁴ Surgical Research Unit, Centre for Eye Research Australia (CERA), University of Melbourne, Melbourne, VIC 3013, Australia.

Matthew M Wilson et al. Int J Ophthalmol. 2022.

. 2022 Jun 18;15(6):1020-1022.

doi: 10.18240/ijo.2022.06.23. eCollection 2022.

Matthew M Wilson¹, Philipp K Roberts^{1

2}, Mark Daniell^{1

3

4}

¹ Corneal Service, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria 3002, Australia.
² Medical University of Vienna, Vienna 1090, Austria.
³ Department of Surgery (Ophthalmology), University of Melbourne, Parkville, VIC 3013, Australia.
⁴ Surgical Research Unit, Centre for Eye Research Australia (CERA), University of Melbourne, Melbourne, VIC 3013, Australia.

No abstract available

Figures

1. Gooderham MJ, Hong HCH, Eshtiaghi P, Papp KA. Dupilumab: a review of its use in the treatment of atopic dermatitis. J Am Acad Dermatol. 2018;78(3 Suppl 1):S28–S36. - PubMed
1. Mayba JN, Gooderham MJ. Review of atopic dermatitis and topical therapies. J Cutan Med Surg. 2017;21(3):227–236. - PubMed
1. Wang FP, Tang XJ, Wei CQ, Xu LR, Mao H, Luo FM. Dupilumab treatment in moderate-to-severe atopic dermatitis: a systematic review and meta-analysis. J Dermatol Sci. 2018;90(2):190–198. - PubMed
1. Halling AS, Loft N, Silverberg JI, Guttman-Yassky E, Thyssen JP. Real-world evidence of dupilumab efficacy and risk of adverse events: a systematic review and meta-analysis. J Am Acad Dermatol. 2021;84(1):139–147. - PubMed
1. Li G, Berkenstock M, Soiberman U. Corneal ulceration associated with dupilumab use in a patient with atopic dermatitis. Am J Ophthalmol Case Rep. 2020;19:100848. - PMC - PubMed